| 2011 | Synthesis and biological evaluation of 1-substituted-3-(6-methylpyridin-2- yl)-4-([1,2,4triazolo[1,5-apyridin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
| 2011 | Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin- 2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
| 2007 | Development of LC/MS/MS assay for the determination of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one (SK3530) in human plasma: application to a clinical pharmacokinetic study | 김대기 | Article |
| 2009 | IN-1130, a novel transforming growth factor-β type I receptor kinase (Activin Receptor-like Kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease | 김대기 | Article |
| 2006 | IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy | 신윤용; 김대기 | Article |
| 2013 | IN-1233-eluting covered metallic stent to prevent hyperplasia: Experimental study in a rabbit esophageal model | 김대기 | Article |
| 2011 | Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice | 김대기 | Article |
| 2020 | Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1H-imidazoles as ALK5 inhibitors | 이화정; 김대기 | Article |
| 2017 | EW-7197, an activin-like kinase 5 inhibitor, suppresses granulation tissue after stent placement in rat esophagus | 김대기 | Article |
| 2018 | EW-7197, an oral transforming growth factor beta type I receptor kinase inhibitor, for preventing peritoneal adhesion formation in a rat model | 김대기 | Article |
